OHSU Knight Cancer Institute Research Groups:OCI Research Group Meetings: Difference between revisions
m (→Schedule) |
Karyn Taylor (talk | contribs) |
||
(13 intermediate revisions by 3 users not shown) | |||
Line 138: | Line 138: | ||
Department of Medical Informatics & Clinical Epidemiology<br> | Department of Medical Informatics & Clinical Epidemiology<br> | ||
hersh@ohsu.edu<br> | hersh@ohsu.edu<br> | ||
| | |Opportunities for Collaboration Between Biomedical Informatics and Basic, Clinical, and Translational Sciences | ||
| | | | ||
|Mac Hall 2201 | |Mac Hall 2201 | ||
Line 151: | Line 151: | ||
| <font color=red>1/4/2013</font> | | <font color=red>1/4/2013</font> | ||
|Hematologic Malignancies | |Hematologic Malignancies | ||
| | |No Meeting | ||
| | | | ||
|Mac Hall 2201 | |Mac Hall 2201 | ||
Line 157: | Line 157: | ||
|<font color=red>1/11/2013</font> | |<font color=red>1/11/2013</font> | ||
|Hematologic Malignancies | |Hematologic Malignancies | ||
| | |Angela Fleischman | ||
Title: Inflammation as a driver of clonal evolution in myeloproliferative neoplasms. | |||
| | | | ||
|Mac Hall 2201 | |Mac Hall 2201 | ||
Line 174: | Line 175: | ||
|-- | |-- | ||
| <font color=red>2/1/2013</font> | | <font color=red>2/1/2013</font> | ||
| | | canceled | ||
| | | | ||
| | | | ||
Line 180: | Line 181: | ||
|-- | |-- | ||
|2/8/2013 | |2/8/2013 | ||
| | |canceled | ||
| | | | ||
| | | | ||
Line 186: | Line 187: | ||
|-- | |-- | ||
| <font color=red>2/15/2013</font> | | <font color=red>2/15/2013</font> | ||
| | |Christopher Amling | ||
| | |Prostate cancer screening and treatment of localized disease | ||
| | | | ||
|Mac Hall 2201 | |Mac Hall 2201 | ||
|-- | |-- | ||
|2/22/2013 | |2/22/2013 | ||
| | |Eric Orwoll/Katrina Goddard | ||
| | |Eric Orwoll <br> | ||
Evolving the OHSU-wide clinical/translational research infrastructure<br> | |||
Katrina Goddard <br> | |||
NW Biobank at Kaiser NW, a source of serum/plasma, DNA, and tissue all linked to electronic medical records | |||
| | | | ||
|Mac Hall 2201 | |Mac Hall 2201 | ||
Line 204: | Line 208: | ||
|-- | |-- | ||
|3/8/2013 | |3/8/2013 | ||
| | | Tania Vu | ||
| | |"Quantum Dot Technology for Functional Assessment of Phosphokinase Signaling in Cancer" | ||
| | | | ||
|Mac Hall 2201 | |Mac Hall 2201 |
Revision as of 14:15, 14 February 2013
Home Faculty Graduate Program Postdocs OHSU Knight Core Facilities
Programs
Res Group Meetings
Cancer Journal Club
Cell/CANB 616
Gen. Inst/R3 Club
CANB 610
Objectives of the OHSU Knight Cancer Biology Research Group Meetings
Cross-departmental workshop composed of students, postdocs, and faculty with shared interest in basic principles and emerging discoveries in Cancer Biology. The goals of the meetings and this wiki:
- Establish a challenging and interactive cross-departmental focus group that will advance understanding of our individual projects and encourage collaborations.
- Provide students and postdocs with training and interactions with faculty interested in Cancer Biology and emerging therapeutics
These meetings are now expanded to include a Translational Cancer Research Group Meeting. The purpose of this meeting is to:
- Serve to foster a Knight translational research incubator for projects and teams leading to multi-investigator cancer program/SPORE funding including the Solid tumors and Hematologic Malignancies programs and the Systems Biology group.
- Meetings will include thematic research and clinical research talks with collaborative and developmental potential and Brainstorming Sessions.
Knight Research Group Activities
Want to join us? All are invited!
- To get on the listserve:
- go to the following web site:
- http://mailman.ohsu.edu/cgi-bin/mailman/listinfo/oncres
- follow the instructions for subscribing
- We meet in Mac Hall 2201
- Fridays 9:00-10:15 AM - see schedule below
- Breakfast provided by the Knight!
- Organizer: Rosie Sears, email searsrATohsu.edu
Member Labs and Affiliations
Lopez Lab Hem Onc
Sears Lab, MMG
Hoatlin Lab, BMB
Thayer Lab, BMB
Lloyd Lab, CROET
McCullough Lab, CROET
Wong Lab, Dermatology, CDB
Zundel Lab, Radiation Medicine, Cancer Biology
Spindel Lab, Primate Center, NGP, Cancer Biology
Jacques Lab, Biomedical Engineering/Dermatology
Gray Lab, OHSU Center for Spacial Systems Biology
- Add your lab here
Schedule
*Red indicates Translational Cancer Research Group Meetings
Date | Presenters | Topic | Links & Comments | Location |
9/21/2012 | Rebecca Block <blockr@ohsu.edu> | “Symptoms of Depression among Adolescent and Young Adult Latino Men with Cancer” | Mac Hall 2201 | |
9/28/2012 | Guang Fan | Hematologic Malignancies - Guang Fan, "Highlights of translational research for Hematologic malignancy in Hemepath division"
Carol Beading, “Ion Torrent technology for AML/MDS mutation testing" |
Mac Hall 2201 | |
10/5/2012 | Larry Sherman | Mechanisms underlying cognitive disturbances in patients undergoing cancer chemotherapy: A possible intervention | Mac Hall 2201 | |
10/12/2012 | Tibor Kovacsovics/William Harv Fleming | Hematologic Malignancies | Mac Hall 2201 | |
10/19/2012 | Wei Huang | Quantitative DCE-MRI as a predictor of therapeutic response in acute leukemia | Mac Hall 2201 | |
10/26/2012 | Jeffrey Tyner/Marc Loriaux | Hematologic Malignancies - Jeffrey Tyner: Functional Genomics on Primary Leukemia Specimens to Identify Novel Driver Oncogenes and Therapeutic Strategies | Mac Hall 2201 | |
11/2/2012 | Jim Korkola | Mac Hall 2201 | ||
11/9/2012 | CANCEL - KNIGHT RESEARCH RETREAT | Skamania Lodge | ||
11/16/2012 | Owen McCarty | Development of coagulation factor probes for the identification of procoagulant cancer cells | Mac Hall 2201 | |
11/23/2012 | CANCEL - THANKSGIVING | |||
11/30/2012 | Brandon Hayes-Lattin/Rebecca Block | Hematologic Malignancies | Mac Hall 2201 | |
12/7/2012 | Thayer Lab | cis-acting elements that control chromosome-wide replication and stability | Mac Hall 2201 | |
12/14/2012 | William Hersh, MD Professor and Chair |
Opportunities for Collaboration Between Biomedical Informatics and Basic, Clinical, and Translational Sciences | Mac Hall 2201 | |
12/21/2012 | Charles Keller | Talk 1: leptomeningeal metastastis as a cytokine-mediated process;
Talk 2: Status of the Pediatric Cancer Biology Program |
Mac Hall 2201 | |
1/4/2013 | Hematologic Malignancies | No Meeting | Mac Hall 2201 | |
1/11/2013 | Hematologic Malignancies | Angela Fleischman
Title: Inflammation as a driver of clonal evolution in myeloproliferative neoplasms. |
Mac Hall 2201 | |
1/18/2012 | Diane Elliot <elliotd@ohsu.edu> | Mac Hall 2201 | ||
1/25/2013 | Zhi and Wassana | Mac Hall 2201 | ||
2/1/2013 | canceled | Mac Hall 2201 | ||
2/8/2013 | canceled | Mac Hall 2201 | ||
2/15/2013 | Christopher Amling | Prostate cancer screening and treatment of localized disease | Mac Hall 2201 | |
2/22/2013 | Eric Orwoll/Katrina Goddard | Eric Orwoll Evolving the OHSU-wide clinical/translational research infrastructure |
Mac Hall 2201 | |
3/1/2013 | Mac Hall 2201 | |||
3/8/2013 | Tania Vu | "Quantum Dot Technology for Functional Assessment of Phosphokinase Signaling in Cancer" | Mac Hall 2201 | |
3/15/2013 | Mac Hall 2201 | |||
3/22/2013 | Mac Hall 2201 | |||
3/29/2013 | CANCEL - SPRING BREAK | |||
4/5/2013 | Mitchell Turker | Chromosome loss, tetraploidy, and aneuploidy | Mac Hall 2201 | |
4/12/2013 | Mac Hall 2201 | |||
4/19/2013 | Mac Hall 2201 | |||
4/26/2013 | Mac Hall 2201 | |||
5/3/2013 | Mac Hall 2201 | |||
5/10/2013 | Mac Hall 2201 | |||
5/17/2013 | Mac Hall 2201 | |||
5/24/2013 | Mac Hall 2201 | |||
5/31/2013 | Mac Hall 2201 | |||
6/7/2013 | Mac Hall 2201 | |||
6/14/2013 | Mac Hall 2201 |